Pierre Toulon

1.7k total citations
85 papers, 1.2k citations indexed

About

Pierre Toulon is a scholar working on Hematology, Internal Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Pierre Toulon has authored 85 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Hematology, 33 papers in Internal Medicine and 15 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Pierre Toulon's work include Blood Coagulation and Thrombosis Mechanisms (38 papers), Venous Thromboembolism Diagnosis and Management (33 papers) and Hemophilia Treatment and Research (16 papers). Pierre Toulon is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (38 papers), Venous Thromboembolism Diagnosis and Management (33 papers) and Hemophilia Treatment and Research (16 papers). Pierre Toulon collaborates with scholars based in France, United States and Italy. Pierre Toulon's co-authors include Mathieu Zuber, Jean‐Louis Mas, Annick Ankri, Charles Marc Samama, Marie-Hélène Fléron, Yves Ozier, Geneviève Leroux, Florence Fischer, Martine Aiach and J.F. Vitoux and has published in prestigious journals such as Blood, Stroke and Annals of the New York Academy of Sciences.

In The Last Decade

Pierre Toulon

82 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre Toulon France 20 511 352 222 219 177 85 1.2k
René van Oerle Netherlands 17 431 0.8× 298 0.8× 251 1.1× 144 0.7× 236 1.3× 31 936
E. C. M. van Pampus Netherlands 19 664 1.3× 414 1.2× 144 0.6× 133 0.6× 263 1.5× 29 1.1k
DM Tollefsen Canada 6 972 1.9× 321 0.9× 165 0.7× 217 1.0× 265 1.5× 8 1.5k
Anne Bauters France 15 633 1.2× 218 0.6× 405 1.8× 441 2.0× 458 2.6× 46 1.5k
Eli Cohen United States 17 387 0.8× 415 1.2× 556 2.5× 438 2.0× 497 2.8× 23 1.5k
Martine Wolf France 14 490 1.0× 222 0.6× 107 0.5× 431 2.0× 152 0.9× 25 1.0k
Tim Nokes United Kingdom 15 499 1.0× 456 1.3× 120 0.5× 200 0.9× 325 1.8× 29 1.0k
Joost J. van Veen United Kingdom 19 532 1.0× 463 1.3× 103 0.5× 240 1.1× 442 2.5× 34 1.2k
R. Luddington United Kingdom 17 907 1.8× 620 1.8× 389 1.8× 326 1.5× 500 2.8× 26 1.7k
Bettina Leschnik Austria 19 526 1.0× 225 0.6× 77 0.3× 149 0.7× 295 1.7× 56 1.1k

Countries citing papers authored by Pierre Toulon

Since Specialization
Citations

This map shows the geographic impact of Pierre Toulon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Toulon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Toulon more than expected).

Fields of papers citing papers by Pierre Toulon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Toulon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Toulon. The network helps show where Pierre Toulon may publish in the future.

Co-authorship network of co-authors of Pierre Toulon

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Toulon. A scholar is included among the top collaborators of Pierre Toulon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Toulon. Pierre Toulon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Toulon, Pierre, et al.. (2024). Four clinical and biological phenotypes in antiphospholipid syndrome: a cluster analysis of 174 patients with antinuclear antibody tests. Frontiers in Immunology. 15. 1361062–1361062. 2 indexed citations
2.
Hollestelle, Martine J., et al.. (2020). Monitoring unfractionated heparin therapy: Lack of standardization of anti‐Xa activity reagents. Journal of Thrombosis and Haemostasis. 18(10). 2613–2621. 18 indexed citations
3.
Lasne, Dominique, Claire Pouplard, Christophe Nougier, et al.. (2019). Factor VIII assays in treated hemophilia A patients. Annales de biologie clinique. 77(1). 53–65.
4.
Zhang, Litao, et al.. (2018). Use of D‐dimer in oral anticoagulation therapy. International Journal of Laboratory Hematology. 40(5). 503–507. 36 indexed citations
5.
6.
Legnani, Cristina, Michela Cini, Dimitrios Scarvelis, et al.. (2009). Multicenter evaluation of a new quantitative highly sensitive D-dimer assay, the Hemosil® D-dimer HS 500, in patients with clinically suspected venous thromboembolism. Thrombosis Research. 125(5). 398–401. 33 indexed citations
7.
Fischer, Florence, et al.. (2007). Evaluation and performance characteristics of the automated coagulation analyzer ACL TOP. Thrombosis Research. 120(5). 733–743. 29 indexed citations
8.
9.
Assous, Noémie, Yannick Allanore, Frédéric Batteux, et al.. (2005). Prevalence of antiphospholipid antibodies in systemic sclerosis and association with primitive pulmonary arterial hypertension and endothelial injury.. PubMed. 23(2). 199–204. 38 indexed citations
10.
Fischer, Florence, et al.. (2005). Evaluation of the automated coagulation analyzer Sysmex® CA-7000. Thrombosis Research. 117(6). 721–729. 22 indexed citations
11.
Toulon, Pierre, et al.. (2001). Intérêt du dosage des D-dimères dans le diagnostic d’exclusion de l’embolie pulmonaire. Annales de biologie clinique. 59(6). 693–700. 2 indexed citations
12.
Toulon, Pierre, et al.. (2001). Sensitivity of the ProC® Global Assay for Protein C Pathway Abnormalities. Thrombosis Research. 104(2). 93–103. 10 indexed citations
13.
Picard, Véronique, A. Bura-Rivière, Joseph Emmerich, et al.. (2000). Molecular bases of antithrombin deficiency in French families: identification of seven novel mutations in the antithrombin gene. British Journal of Haematology. 110(3). 731–734. 15 indexed citations
14.
Toulon, Pierre, et al.. (2000). Screening for abnormalities of the protein C anticoagulant pathway using the ProC Global assay. Results of a European multicenter evaluation. Blood Coagulation & Fibrinolysis. 11(5). 447–454. 20 indexed citations
15.
Toulon, Pierre. (1998). Hemostasis and HIV infection. Annales de biologie clinique. 56(2). 1 indexed citations
16.
Gris, Jean‐Christophe, et al.. (1996). The Relationship between Plasma Microparticles, Protein S and Anticardiolipin Antibodies in Patients with Human Immunodeficiency Virus Infection. Thrombosis and Haemostasis. 76(1). 38–45. 31 indexed citations
17.
Gandrille, Sophie, Michel Vidaud, Martine Aiach, et al.. (1992). Two novel mutations responsible for hereditary type I protein C deficiency: Characterization by denaturing gradient gel electrophoresis. Human Mutation. 1(6). 491–500. 6 indexed citations
18.
Toulon, Pierre, et al.. (1992). Significance of High Levels of Heparin Cofactor II in the Plasma and Urine of Adult Patients with Nephrotic Syndrome. ˜The œNephron journals/Nephron journals. 60(2). 176–180. 8 indexed citations
19.
Brunet, Fabrice, Jean‐Paul Mira, M. Belghith, et al.. (1992). Effects of aprotinin on hemorrhagic complications in ARDS patients during prolonged extracorporeal CO2 removal. Intensive Care Medicine. 18(6). 364–367. 20 indexed citations
20.
Toulon, Pierre, C. Jacquot, Moshe Frydman, Dominique Vignon, & Martine Aiach. (1987). ANTITHROMBIN III AND HEPARIN COFACTOR II IN PATIENTS WITH CHRONIC RENAL FAILURE. Thrombosis and Haemostasis. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by René van Oerle Breakdown of academic impact, for papers by E. C. M. van Pampus Breakdown of academic impact, for papers by DM Tollefsen Breakdown of academic impact, for papers by Anne Bauters Breakdown of academic impact, for papers by Eli Cohen Breakdown of academic impact, for papers by Martine Wolf Breakdown of academic impact, for papers by Tim Nokes Breakdown of academic impact, for papers by Joost J. van Veen Breakdown of academic impact, for papers by R. Luddington Breakdown of academic impact, for papers by Bettina Leschnik
Rankless by CCL
2026